NVO Novo Nordisk

FRANKFURT--The following is a summary of analysts' forecasts for Novo Nordisk A/S (NVO) first-quarter results, based on a poll of seven analysts conducted by Dow Jones Newswires (figures in million danish kroner, EPS, dividend and target price in danish kroner, according to IFRS). Earnings figures are scheduled to be released April 29.

=== 
                 Sales: 
                                                -NovoRapid/ 
1st Quarter        -Total   -Victoza   -Levemir    NovoLog 
AVERAGE            26,975      4,589      4,400      4,998 
Prev. Year         25,200      3,957      4,072      4,682 
+/- in %             +7.0        +16       +8.1       +6.7 
 
MEDIAN             27,037      4,638      4,475      4,974 
Maximum            27,538      4,774      4,521      5,308 
Minimum            26,396      4,397      4,108      4,718 
Amount                  7          7          7          7 
 
Baader-Helvea      27,121      4,638      4,521      4,927 
Deutsche Bank      27,538      4,405      4,452      5,130 
Exane BNP Paribas  26,738      4,774      4,256      4,718 
Jefferies          26,396      4,645      4,108      4,901 
JP Morgan          27,037      4,687      4,506      5,027 
Morgan Stanley     26,700      4,577      4,475      4,974 
Swedbank           27,292      4,397      4,484      5,308 
 
                Operating               Net       EPS 
1st Quarter        profit      PBT   income   diluted 
AVERAGE            11,764   11,304    8,971      3.54 
Prev. Year         13,857   12,485    9,876      3.79 
+/- in %              -15     -9.5     -9.2      -6.7 
 
MEDIAN             11,668   11,214    8,973      3.54 
Maximum            12,241   11,911    9,410      3.69 
Minimum            11,407   10,875    8,591      3.37 
Amount                  7        4        6         7 
 
Baader-Helvea      11,759   11,444    9,148      3.59 
Deutsche Bank      12,241   11,911    9,410      3.69 
Exane BNP Paribas  11,658       --    8,929      3.50 
Jefferies          11,407   10,875    8,591      3.37 
JP Morgan          12,022       --       --      3.63 
Morgan Stanley     11,668       --    9,017      3.54 
Swedbank           11,595   10,984    8,733      3.44 
 
 
             Target price  Rating                  DPS 2016 
AVERAGE            398.50  positive 4  AVERAGE         7.30 
Prev. Quarter      422.20  neutral  3  Prev. Year      6.40 
+/- in %             -5.6  negative 0  +/- in %         +14 
 
MEDIAN             395.50              MEDIAN          7.15 
Maximum            430.00              Maximum         7.64 
Minimum            370.00              Minimum         7.10 
Amount                  6              Amount             3 
 
Baader-Helvea      411.00  Buy                           -- 
Deutsche Bank      370.00  Hold                        7.64 
Exane BNP Paribas  380.00  Neutral                     7.10 
Jefferies          370.00  Hold                        7.15 
JP Morgan              --  Overweight                    -- 
Morgan Stanley     430.00  Overweight                    -- 
Swedbank           430.00  Buy                           -- 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

(END) Dow Jones Newswires

April 27, 2016 07:00 ET (11:00 GMT)

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Mar 2024 to Apr 2024

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2023 to Apr 2024